Mandip Singh Sachdeva, a professor in the FAMU College of
Pharmacy and Pharmaceutical Sciences, has received a $182,126 research grant
from the National Cancer Institute. The funds were awarded to support a project
entitled: “Role of Telmisartan on Intra-Tumoral Distribution of Targeted
Nanoparticles.”
The project’s abstract states that: “Our laboratory has
been working with the use of inhalation and oral delivery of anticancer agents
for treatment of lung cancer. Active targeting of chemotherapeutic drugs
containing nanoparticles may effectively treat adenocarcinomas by achieving
higher concentration at target sites.”
A nanoparticle is a microscopic object that is between 0.1nm
and 100nm. Sachdeva is exploring how an experimental treatment that combines the use of certain nanoparticles with
a drug named Telmisartan might improve the body's ability to fight cancer.
The project began on April 1, 2014 and will continue through
March 31, 2016.
Sacheva has brought more than $25 million in research grants
to FAMU since he began teaching at the university in 1993.